Read more on Brisbane Times

Read more on Book Reporter

The GI endoscopic market includes:

GI endoscopes
Capsule endoscopic devices
Virtual colonoscopy software
Stenting devices
Dilation balloons
Endoscopic retrograde cholangiopancreatography (ERCP) devices
Biopsy forceps
Polypectomy snares
Fine aspiration needles
Specimen and foreign body retrieval devices
Hemostasis devices
Anti-reflux devices
Enteral feeding devices

In 2009, more than 55 million procedures were performed with GI endoscopic devices. Nearly 50% of these procedures were colonoscopies, reflecting the growing frequency of regular colon exams for early diagnosis of colorectal cancer.

Within the gastrointestinal endoscopic device market, companies such as Boston Scientific, Cook Medical, Given Imaging, Olympus and Pentax lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Table of Contents I

1.1 MARKET ANALYSIS AND FORECAST 1
1.2 MARKET BY SEGMENT 2
1.3 TREND ANALYSIS 3
1.4 GI ENDOSCOPES 4
1.5 CAPSULE ENDOSCOPY 5
1.6 VIRTUAL COLONOSCOPY 5
1.7 STENTING AND DILATION DEVICES 6
1.8 ERCP DEVICES 7
1.9 BIOPSY FORCEPS 8
1.10 POLYPECTOMY SNARES 9
1.11 FINE ASPIRATION NEEDLES 9
1.12 SPECIMEN AND FOREIGN BODY REMOVAL DEVICES 9
1.13 HEMOSTASIS DEVICES 10
1.14 ANTI-REFLUX DEVICES 11
1.15 ENTERAL FEEDING DEVICES 11
1.16 COMPETITIVE ANALYSIS 12

RESEARCH METHODOLOGY 13
2.1 RESEARCH SCOPE 13
2.2 IDATA’S 9-STEP METHODOLOGY 13
2.2.1 Step 1: Project Initiation & Team Selection 14
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 15
2.2.3 Step 3: Preparation for Interviews & Survey Design 16
2.2.4 Step 4: Performing Primary Research 17
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 18
2.2.6 Step 6: Market Forecasting 19
2.2.7 Step 7: Identify Strategic Opportunities 21
2.2.8 Step 8: Final Review and Market Release 22
2.2.9 Step 9: Customer Feedback and Market Monitoring 23

OVERVIEW OF GASTROINTESTINAL ENDOSCOPIC DEVICES 24
3.1 INTRODUCTION 24
3.2 PROCEDURE NUMBERS 25
3.3 MARKET ANALYSIS AND FORECAST 25
3.4 MARKET BY SEGMENT 28
3.5 TREND ANALYSIS BY MARKET SEGMENT 35
3.6 MARKET DRIVERS 37
3.6.1 Colorectal Cancer Screening 37
3.6.2 Technological Advancements 37
3.6.3 Aging Population 37
3.7 MARKET LIMITERS 39
3.7.1 Reimbursement Issues 39
3.7.2 Increasing Competition 39
3.8 COMPETITIVE ANALYSIS 40
3.8.1 Market Concentration 45
3.9 MERGERS AND ACQUISITIONS 47
3.9.1 Boston-Scientific and Guidant 47
3.9.2 Olympus and Gyrus/ACMI 47
3.9.3 Nestlé and Novartis 47
3.10 BANKRUPTCIES 48
3.10.1 Curon Medical 48
3.10.2 NDO Surgical 48
3.11 LITIGATION ISSUES 48
3.11.1 Olympus and Given Imaging 48

PROCEDURE NUMBERS 49
4.1 TOTAL PROCEDURES 49
4.2 GI ENDOSCOPES 50
4.2.1 Colonoscopy Procedure Numbers 50
4.2.2 Sigmoidoscopy Procedures 51
4.2.3 Ultrasound Endoscopy Procedures 52
4.3 CAPSULE ENDOSCOPY 53
4.4 VIRTUAL COLONOSCOPY 54
4.5 STENTING AND DILATION PROCEDURES 55
4.6 ERCP PROCEDURES 56
4.7 BIOPSY FORCEPS AND POLYPECTOMY SNARES PROCEDURES 57
4.7.1 Biopsy Procedures 57
4.7.2 Tumor and Polyp Removal Procedures 58
4.8 SPECIMEN AND FOREIGN BODY RETRIEVAL PROCEDURES 59
4.8.1 Foreign Body Retrieval Procedures 59
4.8.2 Specimen Retrieval Procedures 60
4.9 HEMOSTASIS PROCEDURES 61
4.10 ANTI-REFLUX PROCEDURES 62
4.11 ENTERAL FEEDING DEVICES 63

GASTROINTESTINAL ENDOSCOPES 64
5.1 INTRODUCTION 64
5.2 MARKET ANALYSIS AND FORECAST 65
5.3 MARKET FOR GI ENDOSCOPES BY TYPE 69
5.3.1 Colonoscopes 69
5.3.2 Sigmoidoscopes 72
5.3.3 Gastroscopes 75
5.3.4 Duodenoscopes 77
5.3.5 Enteroscopes 79
5.3.6 Ultrasound Endoscopes 81
5.3.7 Double-Balloon Endoscopes 84
5.3.8 Transnasal Endoscopes 86
5.3.9 Natural Orifice Transluminal Endoscopy 88
5.4 REFURBISHMENT AND REPAIR MARKET 88
5.5 MARKET DRIVERS AND LIMITERS 92
5.5.1 Market Drivers 92
5.5.2 Market Limiters 93
5.6 COMPETITIVE ANALYSIS 94

CAPSULE ENDOSCOPY 96
6.1 INTRODUCTION 96
6.2 PROCEDURE NUMBERS 97
6.3 MARKET ANALYSIS AND FORECAST 98
6.4 MARKET FOR CAMERA CAPSULES 100
6.5 MARKET FOR WORKSTATIONS 102
6.6 MARKET FOR DATA RECORDERS 104
6.7 MARKET DRIVERS AND LIMITERS 106
6.7.1 Market Drivers 106
6.7.2 Market Limiters 106
6.8 COMPETITIVE ANALYSIS 108

VIRTUAL COLONOSCOPY 109
7.1 INTRODUCTION 109
7.2 PROCEDURE NUMBERS 110
7.2.1 Potential Market 112
7.3 MARKET ANALYSIS AND FORECAST 114
7.4 MARKET DRIVERS AND LIMITERS 116
7.4.1 Market Drivers 116
7.4.2 Market Limiters 116
7.5 COMPETITIVE ANALYSIS 118

STENTING AND DILATION DEVICES 120
8.1 INTRODUCTION 120
8.2 PROCEDURE NUMBERS 121
8.3 ESOPHAGEAL STENT MARKET 123
8.3.1 Market Analysis and Forecast 123
8.3.2 Market for Esophageal Coated-Metal Stents 125
8.3.3 Market for Esophageal Bare-Metal Stents 127
8.3.4 Competitive Analysis 129
8.3.5 Market for Esophageal Plastic Stents 131
8.3.6 Market Drivers 133
8.3.7 Market Limiters 134
8.4 DUODENAL STENT MARKET 135
8.4.1 Market Analysis and Forecast 135
8.4.2 Market Drivers 137
8.4.3 Market Limiters 137
8.4.4 Competitive Analysis 138
8.5 BILIARY STENT MARKET 139
8.5.1 Market Analysis and Forecast 139
8.5.2 Market for Biliary Coated-Metal Stents 141
8.5.3 Market for Biliary Bare-Metal Stents 143
8.5.4 Competitive Analysis 145
8.5.5 Market for Biliary Plastic Stents 147
8.5.6 Market Drivers 151
8.5.7 Market Limiters 151
8.6 MARKET FOR ESOPHAGEAL DILATION BALLOONS 152
8.6.1 Market Analysis and Forecast 152
8.6.2 Market for Multi-Stage Esophageal Balloons 154
8.6.3 Market for Single-Stage Esophageal Balloons 156
8.6.4 Market Drivers 158
8.6.5 Market Limiters 159
8.6.6 Competitive Analysis 160
8.7 MARKET FOR COLONIC DILATION BALLOONS 162
8.7.1 Market Analysis and Forecast 162
8.7.2 Market Drivers 164
8.7.3 Market Limiters 164
8.7.4 Competitive Analysis 165
8.8 MARKET FOR DUODENAL DILATION BALLOONS 166
8.8.1 Market Analysis and Forecast 166
8.8.2 Market Drivers 167
8.8.3 Market Limiters 167
8.8.4 Competitive Analysis 168

ERCP DEVICES 169
9.1 INTRODUCTION 169
9.2 PROCEDURE NUMBERS 170
9.3 MARKET ANALYSIS AND FORECAST 171
9.4 SPHINCTEROTOMES 176
9.5 BILIARY STONE REMOVAL BALLOONS 178
9.6 BILIARY STONE REMOVAL BASKETS 180
9.7 BILIARY DILATION BALLOONS 182
9.8 BILIARY LITHOTRIPTERS 184
9.9 ERCP GUIDEWIRES 186
9.10 ERCP CANNULAS 188
9.11 MARKET DRIVERS AND LIMITERS 190
9.11.1 Market Drivers 190
9.11.2 Market Limiters 191
9.12 COMPETITIVE ANALYSIS 192

BIOPSY FORCEPS, POLYPECTOMY SNARES, AND FNA DEVICES 195
10.1 INTRODUCTION 195
10.2 MARKET FOR BIOPSY FORCEPS 196
10.2.1 Biopsy Procedures 196
10.2.2 Market Analysis and Forecast 197
10.2.3 Market for Disposable Biopsy Forceps 200
10.2.4 Hot Biopsy Forceps 202
10.2.5 Reusable Biopsy Forceps 204
10.2.6 Market Drivers 206
10.2.7 Market Limiters 206
10.2.8 Competitive Analysis 207
10.3 MARKET FOR POLYPECTOMY SNARES 209
10.3.1 Tumor and Polyp Removal Procedures 209
10.3.2 Market Analysis and Forecast 210
10.3.3 Market Drivers 212
10.3.4 Market Limiters 212
10.3.5 Competitive Analysis 213
10.4 MARKET FOR FINE ASPIRATION NEEDLES 215
10.4.1 Market Drivers 217
10.4.2 Market Limiters 217
10.4.3 Competitive Analysis 218

SPECIMEN AND FOREIGN BODY REMOVAL DEVICES 220
11.1 INTRODUCTION 220
11.2 FOREIGN BODY REMOVAL DEVICES 221
11.2.1 Foreign Body Removal Procedures 221
11.2.2 Market Analysis and Forecast 222
11.2.3 Market Drivers 224
11.2.4 Market Limiters 224
11.2.5 Competitive Analysis 225
11.3 SPECIMEN RETRIEVAL DEVICES 227
11.3.1 Specimen Retrieval Procedures 227
11.3.2 Market Analysis and Forecast 228
11.3.3 Market Drivers 230
11.3.4 Market Limiters 230
11.3.5 Competitive Analysis 231

HEMOSTASIS DEVICES 232
12.1 INTRODUCTION 232
12.2 PROCEDURE NUMBERS 233
12.3 MARKET ANALYSIS AND FORECAST 234
12.4 ELECTROSURGICAL PROBES 239
12.4.1 Overall Market for Electrosurgical Probes 239
12.4.2 U.S. Market for Conventional Electrosurgical Probes 241
12.4.3 Market for Injection-Needle Probes 242
12.5 HEAT PROBES 243
12.6 LIGATION BANDS 245
12.7 LIGATION CLIPS 247
12.8 SCLEROTHERAPY NEEDLES 249
12.9 ARGON PLASMA COAGULATION PROBES 251
12.10 ELECTROSURGICAL GENERATORS 253
12.11 MARKET DRIVERS AND LIMITERS 255
12.11.1 Market Drivers 255
12.11.2 Market Limiters 256
12.12 COMPETITIVE ANALYSIS 257

ANTI-REFLUX DEVICES 260
13.1 INTRODUCTION 260
13.2 POTENTIAL MARKET 261
13.3 PROCEDURE NUMBERS 262
13.4 MARKET ANALYSIS AND FORECAST 263
13.5 MARKET DRIVERS AND LIMITERS 265
13.5.1 Market Drivers 265
13.5.2 Market Limiters 266
13.6 COMPETITIVE ANALYSIS 268

ENTERAL FEEDING DEVICES 270
14.1 INTRODUCTION 270
14.2 PROCEDURE NUMBERS 271
14.3 MARKET ANALYSIS AND FORECAST 272
14.4 MARKET FOR INITIAL ENTERAL FEEDING KITS 277
14.4.1 Market for PEG Kits 277
14.4.2 Market for PEJ Kits 279
14.4.3 Market for PEG/J Kits 281
14.5 MARKET FOR ENTERAL FEEDING REPLACEMENT DEVICES 283
14.5.1 Market for Low Profile Balloons 283
14.5.2 Market for Low-Profile Buttons 285
14.5.3 Market for Replacement Tubes 287
14.6 MARKET DRIVERS AND LIMITERS 289
14.6.1 Market Drivers 289
14.6.2 Market Limiters 290
14.7 COMPETITIVE ANALYSIS 291
ABBREVIATIONS 294

Cancer is the result when the normal growth and division of cells in your body gets out of control. When you think about it, the cells are really quite miraculous. Your entire body is made up of cells, and they tend to grow, divide and generally take care of themselves without any conscious input from you. But sometimes things go awry. Instead of growing new cells as and when needed, cancerous growth continues when there is no need for new cells.

In your colon, this extra growth may initially take the form of small polyps. The mere existence of polyps in your colon does not mean that you have colon cancer. But there is a very good chance that over a period of years, one or more of these polyps could become cancerous. Because there are no symptoms at the beginning, the only way to detect polyps is with a test called a colonoscopy.

Colonoscopy uses a tiny camera on a flexible fiber-optic cable. After some sedation and some lubrication, the camera is inserted into your rectum and threaded up through your lower intestine. The colonoscopy operator and the doctor were able to view the inside of your intestine in real time and search for any abnormalities. The process sounds both embarrassing and painful, but colonoscopy is absolutely essential to maintain good colon health, especially if you are at risk for colorectal cancer. Age is the greatest risk factor. About 90% of all cases of colorectal cancer occur in people over the age of 50.

During the colonoscopy, if your doctor discovers any polyps in your colon, he may take a small sample to determine if they are cancerous. In some cases, your doctor may remove the entire polyp during the colonoscopy. There’s no cause for immediate alarm even if your doctor does discover polyps in your colon. There are actually several different kinds of polyps and not all of them are at risk for becoming cancerous. Adenomas are the polyps with the greatest risk for becoming cancerous and are often removed as soon as they are found. Once again, if you have a colonoscopy and your doctor discovers the presence of polyps, stay calm. Polyps in the colon, even adenomas, are actually quite common and are routinely found and removed in colonoscopies.

Can a regular colon detox prevent the formation of precancerous polyps? Although no definitive link is been established by clinical research, regular colon cleansing could help you avoid development of polyps. One of the risk factors for colorectal cancer is incomplete emptying of your colon. By paying more attention to colon health and performing a regular colon detox, it’s possible for you to be lower your risk of developing dangerous precancerous polyps.

Another risk factor for colorectal cancer is inactivity. When your lifestyle is characterized by lack of activity, waste actually stays in your colon longer. The slow movement and build up of waste in your colon could lead to negative colon health outcomes.

Low fiber, high fat diets have also been implicated in the development of polyps and subsequent growth of colon cancer. Changing your diet and lifestyle could lead to a dramatic improvement in your colon health. By filling your diet with fiber-rich foods and cutting back on fatty foods, you will be greatly lowering your risk for the development of colon cancer. As you start out on this new diet and lifestyle, you may wish to try a colon cleanse and complete colon detox. This will facilitate the emptying of your colon and accelerate your progress toward overall wellness.

Medicare Covers Screening to Detect Colorectal Cancer

Medicare covers a colonoscopy once every two years if you are at high risk for colorectal cancer. High-risk groups are those who have had colorectal polyps or colorectal cancer, people with a family history of colorectal cancer, or anyone with inflammatory bowel disease.

If you’re not in a high-risk group, Medicare will cover a colonoscopy once every ten years, but not within four years of a flexible sigmoidoscopy. There is no minimum age requirement for Medicare to cover colonoscopy.

If you are at least 50 years of age, Medicare also covers a fecal occult blood test once a year, and a flexible sigmoidoscopy once every four years. Barium enema is also covered only if performed on its own, rather than in addition to the other tests.

A fecal occult blood test finds blood in the stool by placing a small stool sample on a chemically treated card, cloth wipe, or pad. A chemical solution is put on the sample, and blood is detected if it turns blue.

Fecal occult blood tests may check for intestinal conditions, including colorectal cancer, but not all blood in the stool is caused by cancer. It could result from eight other conditions, including the use of aspirin or nonsteroidal anti-inflammatory drugs called NSAIDs.

Sigmoidoscopy is a screening tool that refers to examination of the large intestine from the rectum. A sigmoidoscopy is not the same as a colonoscopy, though. A sigmoidoscopy only examines up to the sigmoid, or the most distal part of the colon. A colonoscopy examines the entire large bowel.

Medicare will cover these services without requiring a Part B deductible, and it will cover 100 percent of the fecal occult blood test. If you are in a Medicare private HMO or PPO plan, you may have a copay, though. For the other tests, Medicare will cover 80 percent of the costs, or 75 percent of a colonoscopy or flexible sigmoidoscopy performed in an ambulatory surgical center or hospital outpatient department.

Medicare Supplement Insurance Can Fill in the Gaps in Medicare Coverage

Medicare Supplement Insurance, or Medigap Insurance, can pay for expenses that are not covered through traditional Medicare. Medigap policies must have standardized benefits, but the costs can vary. You may be able to choose up to 12 different Medigap policies (Plans A through L) until June of this year. Then, four of the existing Medigap Plans are being dropped, and two new Medigap Plans are being added.

Each plan has a different set of benefits. The benefits of any Medigap Plan A, for instance, are the same regardless of which insurance company sells it, but the price may vary from different companies. That makes it important to compare companies and plans.

You generally need to have Medicare Part A and Part B to buy Medigap Insurance. You’ll pay a monthly Part B premium, and a premium for the Medigap policy. Medigap Insurance won’t cover your spouse, so you need separate policies.

By taking advantage of this Medicare coverage for screening to detect colorectal cancer, you can stop colorectal cancer before it endangers your health. Medicare Supplement Insurance can also help with any costs that Medicare does not cover.